[269] METTL14 deletion promotes the kidney cancer cell growth, proliferation, migration and invasion either by enhancing the signaling pathway of ATP-P2PX6-Ca2+-P-ERK1/2-MMP9 [270], or by increasing NEAT1 [271] or by increasing BPTF/enolase 2 abundance and glycolytic reprogramming [272]. The gene discussed is METTL14; the disease is kidney cancer.